Biohaven Pharmaceutical Holding Total Assets 2016-2021 | BHVN
Biohaven Pharmaceutical Holding total assets from 2016 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Biohaven Pharmaceutical Holding total assets for the quarter ending September 30, 2021 were $1.131B, a 44.65% increase year-over-year.
- Biohaven Pharmaceutical Holding total assets for 2020 were $0.687B, a 99.55% increase from 2019.
- Biohaven Pharmaceutical Holding total assets for 2019 were $0.344B, a 18.71% increase from 2018.
- Biohaven Pharmaceutical Holding total assets for 2018 were $0.29B, a 97.44% increase from 2017.
Biohaven Pharmaceutical Holding Annual Total Assets
(Millions of US $) |
| 2020 |
$687 |
| 2019 |
$344 |
| 2018 |
$290 |
| 2017 |
$147 |
| 2016 |
$27 |
| 2015 |
$2 |
Biohaven Pharmaceutical Holding Quarterly Total Assets
(Millions of US $) |
| 2021-09-30 |
$1,131 |
| 2021-06-30 |
$846 |
| 2021-03-31 |
$1,003 |
| 2020-12-31 |
$687 |
| 2020-09-30 |
$782 |
| 2020-06-30 |
$424 |
| 2020-03-31 |
$533 |
| 2019-12-31 |
$344 |
| 2019-09-30 |
$439 |
| 2019-06-30 |
$491 |
| 2019-03-31 |
$245 |
| 2018-12-31 |
$290 |
| 2018-09-30 |
$195 |
| 2018-06-30 |
$239 |
| 2018-03-31 |
$126 |
| 2017-12-31 |
$147 |
| 2017-09-30 |
$185 |
| 2017-06-30 |
$214 |
| 2017-03-31 |
$60 |
| 2016-12-31 |
$27 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$8.002B |
$0.064B |
|
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
|
